PGHH Announces Unaudited Financial Results for Quarter Ended Sep 30, 2025
PGHH reports ₹1150 crore in sales, a 1% YoY growth, and a PAT of ₹210 crore for the quarter ended September 30, 2025. The company focuses on integrated growth strategy and superior product portfolio.
The financial results show a slight growth in sales. The announcement provides insights into the company's strategy.
The announcement primarily reports financial results, with a slight increase in sales and a mention of the company's strategic focus. No strong positive or negative indicators are present.
* PGHH announced its financial results for the second quarter ended September 30, 2025. * Sales reached ₹1150 crore, a 1% increase compared to the previous year. * Profit After Tax (PAT) stood at ₹210 crore. * Kumar Venkatasubramanian, Managing Director, stated that the company's integrated growth strategy focuses on a superior product portfolio, productivity, constructive disruption and an agile organization to deliver sustainable growth and value creation.
What to do with a filing like this
Procter & Gamble Hygiene and Health Care Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Procter & Gamble Hygiene and Health Care Limited. Read the original for the full detail.